Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

A Study to Assess the Relative Bioavailability After a Single Inhalation Administration of Treprostinil Palmitil Inhalation Powder (TPIP) Formulation 2 (F2) to TPIP Formulation 3 (F3) in Healthy Participants

← catalyst calendar

NCT07102316

Sponsored by Insmed Incorporated (industry) · INSM — their whole pipeline →.

Phase
Phase 1
Status
Completed
Study type
Interventional
Design
Randomized · None · Treatment
Enrollment
42actual
Sites
1
Country
United States

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
Start2025-08-19actualWhen the study began enrolling
Primary completion2025-10-25actualThe date the last participant is measured for the primary outcome — the readout window
Study completion2025-11-03actualThe whole study's end, after follow-up
First posted2025-08-03actualWhen this record first appeared on the registry
Results postedWhen the sponsor posted results to the registry
Record updated2025-11-21actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Condition

  • Healthy Volunteers

Interventions

  • Drug: TPIP F2 — also filed as INS1009
  • Drug: TPIP F3 — also filed as INS1009

Primary outcomes

what the primary-completion date above is the date OF
Maximum Observed Plasma Concentration (Cmax) of Treprostinil (TRE)
measured Pre-dose and post-dose at multiple timepoints up to Day 10
Area Under Plasma Concentration-Time Curve From 0 to Last Time Point With Quantifiable Concentration (AUClast) of TRE
measured Pre-dose and post-dose at multiple timepoints up to Day 10
Area Under Plasma Concentration-Time Curve From 0 to Infinity (AUCinf) of TRE
measured Pre-dose and post-dose at multiple timepoints up to Day 10

Permalink · INSM's whole pipeline · Catalyst calendar · Every registered study · What changed